{
    "clinical_study": {
        "@rank": "109350", 
        "arm_group": [
            {
                "arm_group_label": "vitamin D3, prenatal multivitamin", 
                "arm_group_type": "Experimental", 
                "description": "vitamin D3 50,000 unit/week for 8 weeks, daily prenatal multivitamin containing elemental calcium 250 mg/day and vitamin D3 400 unit"
            }, 
            {
                "arm_group_label": "prenatal multivitamin", 
                "arm_group_type": "Active Comparator", 
                "description": "daily prenatal multivitamin containing elemental calcium 250 mg/day and vitamin D3 400 unit"
            }
        ], 
        "brief_summary": {
            "textblock": "-  Pregnant women in 24-26 gestational week will be recruited.Serum calcium and 25(OH)D\n           will be evaluated and women with mild hypocalcemia (serum calcium 8-8.6 mg/dl) and\n           25(OH)D less than 30ng/ml will be entered to study. .\n\n        -  Excluding criteria are: gestational diabetes or diabetes before pregnancy, severe\n           preeclampsia, chronic hypertension, fetal anomaly, oligohydramnios or polyhydramnios,\n           parathyroid disorders, hepatic or renal diseases, malnutrition , use of anti-\n           convulsive and immunosuppressive drugs.\n\n        -  Participants will randomly assigned in to two groups of intervention and control groups\n           .Randomization will be done by random number generator.  Intervention group will\n           receive weekly vitamin D3, 50,000 unit for 8 weeks plus daily prenatal multivitamin\n           containing elemental calcium 250 mg/day and vitamin D3 400 unit , control group will\n           receive daily prenatal multivitamin.\n\n        -  At the time of delivery, serum calcium, 25(OH)D of mothers, maternal weight gain during\n           study , Serum calcium and 25(OH)D of newborns and neonatal growth indices ( length,\n           weight, head circumference ) will be compared between two groups."
        }, 
        "brief_title": "Vitamin D Treatment and Hypocalcemic Pregnant Women", 
        "condition": "Pregnancy Complications", 
        "condition_browse": {
            "mesh_term": [
                "Hypocalcemia", 
                "Pregnancy Complications", 
                "Vitamin D Deficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        gestational age of 24-26weeks,mild hypocalcemia (ca=8-8.6mg/dl),singleton pregnancy,  body\n        mass index (BMI) of 19-26 -\n\n        Exclusion Criteria:\n\n        moderate  to sever hypocalcemia(ca<8mg/dl),  gestational diabetes or diabetes before\n        pregnancy, severe preeclampsia, chronic hypertension, fetal anomaly, oligohydramnios or\n        polyhydramnios, parathyroid disorders, hepatic or renal diseases, malnutrition , use of\n        anti- convulsive and immunosuppressive drugs\n\n        -"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02021864", 
            "org_study_id": "hypocalcemia of pregnancy"
        }, 
        "intervention": [
            {
                "arm_group_label": "vitamin D3, prenatal multivitamin", 
                "description": "vitamin D3 50,000 unit/week for 8 weeks", 
                "intervention_name": "vitamin D3 50,000 unit", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "vitamin D3, prenatal multivitamin", 
                    "prenatal multivitamin"
                ], 
                "description": "daily prenatal multivitamin containing elemental calcium 250 mg/day and vitamin D3 400 unit", 
                "intervention_name": "prenatal multivitamin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cholecalciferol", 
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "hypocalcemia, pregnancy, vitamin D", 
        "lastchanged_date": "January 19, 2014", 
        "location": {
            "contact": {
                "email": "Abotorabi4242@yahoo.com", 
                "last_name": "shokooh Abotorabi, assistant professor", 
                "phone": "00989121822663"
            }, 
            "facility": {
                "address": {
                    "city": "Qazvin", 
                    "country": "Iran, Islamic Republic of"
                }, 
                "name": "Qazvin university of medical science, Kosar hospital"
            }, 
            "investigator": {
                "last_name": "shokooh Abotorabi, assistant professor", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "official_title": "Effect of Treatment of Vitamin D Deficiency During Pregnancy on Hypocalcemia", 
        "other_outcome": [
            {
                "measure": "maternal weight gain", 
                "safety_issue": "No", 
                "time_frame": "12-14 weeks"
            }, 
            {
                "measure": "neonatal serum calcium level", 
                "safety_issue": "No", 
                "time_frame": "12-14 weeks"
            }, 
            {
                "description": "neonatal growth indices include neonatal weight, head circumference, length", 
                "measure": "neonatal growth indices", 
                "safety_issue": "No", 
                "time_frame": "12-14 weeks"
            }
        ], 
        "overall_contact": {
            "email": "Hashemipour.sima@yahoo.com", 
            "last_name": "Sima Hashemipour, assisstant prefessor", 
            "phone": "00989123575592"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Iran: Ministry of health and medical education.", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "women in 24-26 weeks of pregnancy will be enrolled.Outcomes will be measured at delivery time.", 
            "measure": "percentage of hypocalcemic subjects at the ens of study", 
            "safety_issue": "No", 
            "time_frame": "12-14 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02021864"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sina Hospital, Iran", 
            "investigator_full_name": "Dr. Sima Hashemipour", 
            "investigator_title": "assistant professor of endocrinology and metabolism", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Changing of maternal mean calcium level", 
            "safety_issue": "No", 
            "time_frame": "12-14 weeks"
        }, 
        "source": "Sina Hospital, Iran", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dr. Sima Hashemipour", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}